Redirecting Immune Memory from Pathogens or Childhood Vaccines to Target Cancer VerImmune is advancing Anti-tumor Immune Redirection (AIR): A Breakthrough Therapy that Redirects Pre-Existing Immune Memory from Childhood Vaccination or Infection to Fight Cancer

188 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Visualize live-cell function at scale. CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique insights to drug discovery. A revolutionary approach to studying cell biology, powered by microchips. Electrophysiology, CMOS, Phenotypic Screening, Electrochemistry, Cell measurement, and Cell manipulation

87 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Complete genes for complete cures Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them. Biotechnology, DNA therapeutics, Gene therapy, CRISPR, and Biological engineering

113 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A Biotech Company 100% Focused On Advancing New Therapies For Childhood Cancer A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer

295 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Our mission is to discover, develop and deliver next generation cancer therapies. G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos. Cancer / Oncology, Drug Discovery and Development, and Biotechnology

160 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Therapeutics for the Disease of Aging Immune therapy platform targeting Dark Genome antigens that contribute to aging, cancer, diabetes, and neurodegenerative diseases Oncology, Aging, Dark Genome, ALS, Diabetes, and Longevity

198 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Making it possible CLEAN BIOLOGICS is a CDMO for Viral vectors, Viral vaccines and oncolytic viruses and Biosafety testing for biological products. As well as a CMO for MCB & WCB production. GMP compliance

63 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient. French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...) 3 major R&D axes: - Developing in vivo models and cell-based assays - Mimicking the human biology by humanizing the tumor microenvironment in mice - Studying the microbiota in cancer patients Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and Cancer

167 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Depixus SAS, based in Paris, is a life science technology company pioneering a groundbreaking technology based on magnetic force spectroscopy. This innovative technology provides real-time analysis of individual biomolecular interactions at scale, enabling researchers to decode disease mechanisms and unlock faster routes to more effective therapies. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics

159 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech

137 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Leader in advanced optical spectroscopy with solutions dedicated to bioprocess Raman monitoring & laser characterization Leader in bioprocess analytical monitoring, RESOLUTION Spectra Systems is now part of Merck PAT, Raman spectroscopy, Chemometrics, Bioprocess, Bioprocess analytics, Cell culture monitoring, Upstream process development monitoring, Process Analytical Technology, Downstream processes control, In-line monitoring, and Real-time monitoring

38 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

See beyond your cells. Advanced imaging solutions for research excellence. Logos Biosystems is the life science solutions of Aligned Genetics, Inc., dedicated to the development and commercialization of innovative technologies to support the life science research community. Since its founding in 2008, Logos Biosystems has been developing a series of automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis.

20 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune

398 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library

336 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Phenocell is a research-based biotechnology company specialized in the creation, production, and commercialization of cellular models & bioassays for research and drug discovery. We are your designated partner for open innovation projects, let's reach out! Using the Nobel-prize winning technology of cellular reprogramming, we create foot-print free, feeder-free, hiPSC that are further differentiated into somatic cells and amenable to 3D projects. Large batches of qualified cells can be produced and used in unique phenotypic assays to repurpose existing drugs or discover new compounds. Phenocell has specific expertise in the production of: -human skin cells: sebocytes, melanocytes and keratinocytes -human retinal …

67 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing

428 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI

264 similar entities Type: Startup Activities: deeptech hrtech biotech Technologies: Synthetic Biology

A thriving life science community for entrepreneurs and leaders and the ideal environment for businesses to succeed 🧪 Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs. Science, Technology, Manufacturing, Research , Research and Development, Enterprise, Logistics, …

75 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

Expert in microorganism detection & enumeration in the environment C4Hydro is a biotechnology company based out of GRAND LUMINY TECHNOPOLE ZONE LUMINY 163 AVENUE DE LUMINY, MARSEILLE CEDEX 09, France. Biotechnologies, Bactériologie, Légionelle, Legionella pneumophila, Environnement, and Microorganismes

37 similar entities Type: Startup Activities: biotech deeptech cleantech greentech

PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapies with minimally-invasive delivery technology to treat major eye diseases. Our mission is to develop life-changing solutions for patients with diseases leading to sight loss.

83 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Cyto-genomic technology to measure chromosomal health Cell Environment is a company created in 2016 that developed a new automated cyto-genomic approach combining new cytogenetics techniques with molecular genetics, based on 20 years of academic and private research. It allows to precisely analyse repetitive sequences (50% of the genome) as telomeres & centromeres and detect other chromosomal aberrations. This technology can be applied to better stratify populations for precision medicine in oncology for instance, to help diagnose some conditions as infertility or prenatal conditions, to measure toxic effects of certain treatments (in oncology) or of radiations, to measure the quality of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera Cellvax, founded in 2001, is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis (OA) fields. Cellvax is a fast-growing technology-driven preclinical service company. Today, Cellvax directly employs and through R&D collaborations motivated and differently skilled scientists and engineers, working in interdisciplinary teams on several innovative products. Preclinical studies CRO, Animal models, Cancer, Osteoarthritis, Bio-markers, …

64 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc...

375 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models

58 similar entities Type: Startup Activities: biotech it services Technologies: Generative A.I. A.I.

Proteins Structures Got Easier With Crystallophores Emerged from academic research, POLYVALAN (IBS & ENS Lyon Spin-off company) is a young innovative company founded in December 2016 dedicated to structural biology. POLYVALAN competitive edge is its unique chemical approach allowing significant gain of effectiveness, time and/or precision for protein structure determination that allows an optimal use of the existing large equipments. structural biology, protein crystallization, crystallization screening, nucleating agent, phasing agent, crystallophore, structure determination, X-ray crystallography, and drug design

59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products

61 similar entities Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology

New view for cancer Therapeutic Sirius Neosight is an innovative technological breakdown company which aims to become a key player in the detection of subclashed neo-cancers, relapses and therapeutic monitoring of patients thus offering a new look to doctors on the therapeutic efficiency implemented. Sirius Neosight operates a patented from a patented rupture technology from a consortium of academic laboratory experts in the field.

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity

333 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

INRAE research unit - Environmental biorefinery Laboratoire de Biotechnologie de l'Environnement - Unité propre de recherche de l'INRA Biotechnology, Process engineering, Modelisation, and Microbial ecology

80 similar entities Type: Startup Activities: biotech deeptech

What You See Is What You Seq - Revolutionary cell analysis solution for fundamental, translational & pharma/biotech R&D Minos Biosciences is on the path to bridge molecular and cell biology in a manner never achieved before that will, in turn, allow scientists to uncover the full picture of cell diversity and dynamics. By combining multi-omics analysis with phenotypic analysis at cell resolution and at high throughput, Minos’ solution provides a new paradigm in cell analysis that will open up new frontiers in life science research, precision medicine and diagnostics.

66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Lontra Ventures is an Austin, Texas based entrepreneurial consultancy with two core specialties: Life Science Consulting: Specialty Drug Commercialization & Selling Value Added Services to Pharmaceutical Manufacturers Technology: Business Development & Strategic Sales for High-Growth Companies

63 similar entities Type: SMB Activities: biotech consulting Technologies: Synthetic Biology

A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation

520 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Ion channel and GPCR drug discovery using innovative KnotBody technology Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

186 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Delivering the next generation gene therapies AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors Gene Therapy, Ophthalmology, and Rare diseases

338 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Cellesce specialises in the development, scale up and manufacture of PDOs (patient-derived organoids) Cellesce Ltd is a biochemical engineering company based in Cardiff in the UK. Cellesce specialises in the development, scale up and manufacture of organoids (PDOs). Cell expansion, Organoid culture, Drug discovery, Oncology, Bioprocess, and 3D Cell Culture

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking the access to innovative ingredients and APIs from cannabis, thanks to plant biotechnology. STH BIOTECH develops unique and reliable plant-biotech process to produce cannabinoids at high yield & low cost.

63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Believe in Nature, belong to Future BGene aims at developing sustainable and resilient production ways for high value added, biobased molecules. To this end, BGene develops expertise in domains such as molecular biology, microbiology, biochemistry, process engineering and computer sciences. Food and feed, pharma, cosmetics, chemistry, and environment are among the diverse markets that BGene can address thanks to the cutting-edge bioprocesses developed by BGene know-how. Strain engineering, Microorganism chromosome engineering, Synthetic Biology, Molecular Biology, Bioinformatics, Bioprocess, and Enzyme Engineering

69 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials Synthetic Biology

Dyameo is a research company & amp; Development in the field of medical devices which designs aid probes for the diagnosis of in-vivo cancer cells. This medical device, makes it possible to answer the question: "Are these cells cancerous?", And that in a simple, clear and instant manner. This rupture solution proposes to discriminate cancer cells at an early stage, during endoscopic examinations. Medical devices, medtech, and help with in-vivo cancer diantics

63 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Explore the Unseen BioAxial is now part of Telight. Please follow our news at Telight LinkedIn page https://linkedin.com/company/telight TELIGHT specializes in a field of instruments employing light optics, in particular, providing innovative types and solutions for light microscopy. Super Resolution Microscopy, Fluorescence Microscopy, Conical Diffraction Optical Components, Nanoscopy, Living Cell Imaging, Low phototoxicity, Standard Workflow, Multicolor Imaging, and Intuitive

25 similar entities Type: Startup Activities: nanotech deeptech Technologies: Synthetic Biology

Cell Culture Monitoring Instruments IPRASENSE revolutionizes cell analysis with innovative technologies for automated cell counting and real-time visualization, ideal for research and quality control. Cell culture monitoring, Lensless Lensfree Imaging, Video microscopy, Time lapse Imaging, Automatic cell count and viability analysis, High throughput cell, Inside your incubator, cell count, cell counting, cell viability, cell viability analysis , cell monitoring, and angiogenesis

103 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Twinkling reagents for in vivo protein studies: FAST, splitFAST, CATCHFIRE The Twinkle Factory offers exclusive twinkling reagents for life science research: flurogenic ligands for FAST and split FAST, protein fluorescent reporters, and fluorogenic molecular glues for CATCHFIRE, a self reporting protein dimerizer. Protein-protein interactions, high content analysis, anaerobe metabolic engineering, are our users keywords. The Twinkle Factory is dedicated to speed-up the dissemination of breakthrough fluorescent technologies across the life sciences community. molecular glues, protein-protein interactions, and fluorescent proteins

8 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Large-scale DNA synthesis technology that harnesses natural enzymes. Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information. Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnology

93 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

574 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Modulating T-regulatory cells to balance immunity Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.

185 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Engineering a Sustainable Future We are a strain development company. We engineer purpose-built secondary genomes that facilitate the bio-production of high value chemicals and enzymes. Inline with the circular economy, we are currently establishing a biorefinery that uses second generation sustainable feedstocks for fermentations. Biotechnology, Genome Engineering, Synthetic Biology, pigments, and fermentation

103 similar entities Type: Startup Activities: cleantech deeptech greentech Technologies: Synthetic Biology

Focused on generating precision medicines by leveraging the power of single-cell technologies One Biosciences leverages the power of single-cell analysis to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat conditions. One Biosciences is an integrated discovery engine combining a multi-disciplinary team with in-house computational capabilities. One Biosciences is backed by Institut Curie and Home Biosciences.

71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

European Distributor of innovative cell culture products KDBIO is distributing advanced cell culture devices used for producing monoclonal antibodies, and 3D culture plates for generating multiple spheroid replicates per well, as well as 3D culture plates with nanofiber scaffolds. G-Rex culture systems can be purchased from KDBIO in the EU. Distribution, monoclonal antibodies, 3D culture, CAR-T, and Patient-derived spheroids

54 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

R&D stage veterinary therapeutics biotechnology company based in Cambridge, UK The PetMedix channel will soon be discontinued as we join forces with Zoetis. Follow the Zoetis channels to stay connected and for the latest updates! Biotechnology, Drug Development, Drug Discovery, Therapeutic Antibodies, Monoclonal Antibodies, Companion Animal, Veterinary Medicine, and Research and Development

62 similar entities Type: Startup Activities: pettech biotech deeptech Technologies: Synthetic Biology

Igyxos develop more effective/efficient infertility treatment for patients Igyxos is a biotechnology company based out of CENTRE INRAe VAL DE LOIRE SITE DE TOURS, NOUZILLY, France. Biotechnologie, Fertilité, and anticorps monoclonal

194 similar entities Type: SMB Activities: biotech healthtech Technologies: Synthetic Biology

Life Sciences Advisors. UK | EU | North America We are a niche life sciences advisory firm, and a full service law firm, with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law

73 similar entities Type: Startup Activities: biotech deeptech privacytech legaltech Technologies: Synthetic Biology

Redefining Synthetic Lethality beyond HRD Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion. drug discovery, precision oncology, and biotechnology

62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We digitalise preclinical studies to increase welfare and research quality. TrackPaw Scientific's deep tech solution for 24/7 monitoring of early stage pharmaceutical development offers improved animal welfare together with better study outcomes. Biotechnology , Drug development, Machine learning, Artificial Intelligence, Deep tech, Preclinical research, Animal welfare, and 3R

108 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

662 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology

265 similar entities Type: Startup Activities: deeptech biotech nanotech Technologies: Synthetic Biology

Proteins For Sustainability Cocoon Bioscience specializes in the manufacturing of high performance growth factors and enzymes using an automated platform leveraging cocooned insects as natural, low cost bioreactors.

173 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Precision Protein Antibiotics Glox Therapeutics Ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target Gram-negative Antimicrobial Resistant (AMR) pathogens.

144 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Imaging for discoveries Molecular Imaging in Real Time Biospace Lab - originally Biospace Mesures - was founded in 1989 by Nobel Prize winner Georges Charpak to provide fellow researchers in biology with innovative imaging tools based on his discoveries in high-energy physics and particle detection. Since then, Biospace Lab has pursued and created strong links with medical, pharmaceutical and scientific communities to bring relevant and creative solutions to biomedical imaging needs. Today, Biospace Lab range of instruments, developed with patented technologies, is dedicated to high-performance imaging for pre-clinical research in drug discovery and biology. Biospace Lab instruments and software are …

62 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

We see the future in cells CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale. CellVoyant is built on foundational work from the Carazo Salas lab at the University of Bristol. We’re working at the exciting intersection of cell biology, computer vision, engineering, and machine learning to industrialise next-generation science from research into the real world. Our mission is bold and ambitious and we have …

71 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation.

438 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Pioneering a new era in precision medicine for women's health A clinical-stage biotechnology company pioneering a female-focused precision medicine approach using validated biobanks for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in women's health. ovarian cancer, endometrial cancer, fibrosis, endometriosis, post surgical adhesions, surgery, women's health, fitness, health, lifestyle, precision medicine, Artificial Intelligence, Machine Learning, Biobank, gynecology, reproductive medicine, infertility, cervical cancer, pcos, femtech, life sciences, and healthcare

245 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology A.I.

Innovating vision RhyGaze AG is pioneering a transformative approach with cone optogenetics, which has the potential to revolutionize vision restoration for patients suffering from blindness. pharmaceutical development, optogenetics, gene therapy, ophthalmology, and pharmaceutical research

118 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

It is a company that is the first agency that has a global scale -derived organoid. Based on more than 400 organoid banking systems, garden -based platforms using autoimmune systems, genome analysis -based genetic variations, disease modeling using genetic scissors, and developing new drug -based growth factors based on ECM -based ECM -based growth factors, cooperation with leading domestic and overseas companies and institutions in the field of tumor and regenerative medicine. there is.

92 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Cell Signaling Technology for Organ Repair and Regeneration Cell Signaling Technology for Organ Repair and Regeneration We care for liver Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem Cell therapy, Acquired liver diseases, Liver diseases, liver based genetic diseases, NASH, ACLF, Antibodies, Clinical stage, Chronic liver disease, Fatty liver, Acute liver disease, Regenerative medicine, Biotech, and Biotechnology

155 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis

110 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Providing essential, standardized tools to accelerate breakthroughs in human health Microfluidics | Cytometry | Imaging Standard BioTools delivers the leading proteomic and multi-omic solutions that enable researchers to discover unique biological insights not accessible by other technologies. Mass Cytometry, Tissue Imaging, NGS Library Prep, Genotyping, Gene Expression, Copy Number Variation, Real-Time PCR, and Single-Cell Genomics

184 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for …

40 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Research center & amp; Health development Bionoveo offers project leaders, industrial or academic, biological, technical and methodological skills and resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes.

283 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

3D cell shape + AI to bring the right therapies to the right patients sooner Sentinal4D is an AI-powered cancer drug discovery and development company, with close ties to the Institute of Cancer Research. Sentinal4D represents a collaboration of physics, biology and artificial intelligence to drive novel cancer therapy candidates with a high probability of clinical success. Artificial Intelligence, Computer Vision, Systems Biology, and Drug Discovery

108 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

An evolution in cell line engineering. High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics

171 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases neurodegeneration, RNA therapeutics, physiological upregulation, post-transcriptional upregulation, mRNA, ASO, and SINEUP

279 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

At Bioscibex, we are redefining bioprocessing with innovative single-use bioreactor solutions tailored for modern biologics and cell therapy manufacturing. Our mission is to empower researchers and manufacturers with tools that simplify processes, enhance scalability, and improve efficiency.

260 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Targeting CCN signaling to treat fibrosis Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

166 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Smart active ingredients, safer sun exposure Catalonia Exponential Leader 2023 Roka Furadada’s mission is to reduce the incidence of skin cancer through research, development and production of active ingredients and medical devices, with high efficiency and low toxicologic and environmental impact OUR PURPOSE Roka Furadada wants to help to prevent and reduce the incidence of skin cancer. HOW ARE WE GOING TO DO IT? Developing the first intelligent ultra violet radiation filter: SMART UV, with new molecules that entail therapeutic activity to prevent and treat diseases associated with sun exposure. Cosmetics, Raw Materials , Ingredients, Cosmetic Ingredients, Sunscreen, Sun protection …

38 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

StemInsure®: Your Younger Cells For Life® Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients.

61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Cell Tree Analytics, somatic mutation tracking, clonal structure quantification, check out our Cell Tree Rings study here https://www.biorxiv.org/content/10.1101/2022.12.14.520419v1 mass spec proteomics, aging

68 similar entities Type: Startup Activities: deeptech greentech Technologies: Synthetic Biology

Unlocking the therapeutic potential of protein stabilisation Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.

163 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss

133 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We're on a mission to cure blindness with our transformational platform of advanced therapies Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care.

71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Bringing precision to the power of biologics with pioneering use of synthetic nanoclays for regenerative medicine. Renovos Biologics Ltd. (Renovos) is a biotech/medtech company focussed on the development of its patented synthetic nanoclay, RENOVITE®, as a drug delivery platform for regenerative medicine and beyond. Regenerative Medicine, Biomaterials, Drug Delivery, Medical Devices, Pharmaceuticals, Stem Cells, Orthopaedics, and Biotechnology

121 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

InvenireX is democratizing detection of nucleic acid biomarkers InvenireX is developing real-time, ultra-sensitive Nucleic Acid detection instrumentation powered by the latest object-detection neural networks, to empower our Scientists to accelerate life-sciences research.

89 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations. Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine

208 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unleashing biotech innovation for a greener and fairer future For those creating a more sustainable future with biotechnology, we use AI and computational modelling to help precision fermentation alt protein companies optimise their downstream processing, so they can de-risk their ventures, speed up R&D and reduce costs. Biotechnology, Bioprocessing, Biomanufacturing, Precision Fermetation, ClimateTech, Alternative Protein, Computational Modelling, and Downstream Processing

188 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Light Activated Technologies for treating cancers and rare diseases Lightox has developed a new drug for the treatment of early stage oral cancers. The topically applied formulation allows for specific delivery to the lesion and is activated by a specific wavelength of light.

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

An early-stage oncology company aiming to treat solid tumors SOLID Therapeutics is an early-stage oncology company spun out of CBMR at the University of Copenhagen. We are developing novel cancer therapeutics with dual mode of action targeting both cancer cells and immune cells to treat solid tumors.

107 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies

408 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing

299 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Building Better Biology At MarraBio we design, engineer and construct bacterial protein polymers, that contain the biological messages that cells need to grow, divide and behave properly. Cells grown on an industrial scale for research, agricultural or therapeutic use need to be supplied with the right signals. We provide a multi-functional, cost effective solution in a single, easy to use material. Find out more at https://www.marrabio.com/ Protein Engineering, Protein Production, Cellular Agriculture, Cultivated Meat, Research Reagents, Stem Cell Expansion, and Industrial Scale Cell Culture

138 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Lab-in-a-cell-devices Dynamic film about cell sensing SPAchip® technology is based on intracellular silicon microchips printed with multiple fluorescent probes to analyse and monitor cellular pathways at real time intracellular processes. The cell-based assays based on SPAchip® are compatible with High Content Screening platforms and imaging analysers. Suspended planar arrays, single cell analysis, cell signaling, flow cytometry, vaccines, and immunothepary

66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl. Originating as a start-up from the University of Modena and Reggio Emilia developing and producing innovative products for pre-clinical and clinical applications of cell-based technologies for regenerative medicine and oncology, the cell technology company aims to fill therapeutic gaps for the many still incurable diseases by manufacturing smart treatments based on gene-modified cells with a specific focus on cancer With its team of leading cell therapy experts, Evotec (Moderna) adds a high-quality cGMP manufacturing site to the EVOcells platform increasing capacity, critical expertise, and capabilities …

125 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Casting light on the microbiome We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life. microbiome, precision medicine, biotechnology, diagnostics, immuno-oncology, and companion diagnostics

72 similar entities Type: Startup Activities: deeptech biotech

Technology to ignite the biology revolution We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists'​ ability to use synthetic biology on a scale not currently possible. Biotechnology, Synthetic Biology, DNA synthesis, Gene synthesis, and synbio

165 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Platform to engineer cancer killing viruses using synthetic biology. Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency. Our first indication is liver cancer. We are based in New York City and backed by amazing investors. (YC S21)

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work

215 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Precision Drugs against Eucaryotic Pathogens ASTRA Therapeutics is a Drug Discovery company with a mission to design and develop novel, precision engineered drugs against a whole range of Eukaryotic Pathogens.

505 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Exploiting a new class of tumour specific antigens for cancer therapy A newly established NewCo developing therapeutics targeting a novel class of tumour-specific antigen. TCR-T cells, Immuno-oncology, Vaccines, Bi-specifics, Splicing, Epigenetics, Oncology, T cell biology, and Antigen presentation

170 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerate your cell-line engineering projects with powerful automation and custom services! Accelerate your cell-line engineering projects with powerful automation solutions and custom services! induced pluripotent stem cells, CRISPR-Cas9, genome-editing, services, and single-cell cloning

32 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Reinventing Chemistry for Life Sciences The leading innovator and manufacturer of photoreactors, metabolites and LEDs since 2008 Metabolite synthesis, photochemistry, research instrument, and photoreactor

88 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Biotal is a biotechnology company that is looking for, develops and values ​​innovative marine biomolecules. The unique expertise and know-how of biiotal allow the identification, characterization and marketing of molecules with very high potential for various sectors such as cosmetics, pharmaceutics or neutraceutics. Blue biotechnology, microbiology, biodiversity, and production of polymers

78 similar entities Type: Startup Activities: biotech deeptech manufacturing

Make with Biology Amino Labs' mission is to make biotechnology learning and innovation accessible to teenagers, educators, and adults. Youtube: https://www.youtube.com/c/AminoLabs Education, Genetic Engineering, STEM, Hands-on Experiments, Zero to Genetic Engineering Hero, biology kits, STEAM, and science education

71 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

605 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology